AACC uses cookies to ensure the best website experience. Continuing without changing cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy


Features


The COVID-19 pandemic shows data that health screenings, including cervical screenings for women, have dropped. Experts recommend clinical laboratorians to prepare to advise health systems and clinicians not only on test selection and interpretation, but also how various screening efforts should restart.
Genetic testing during the perimortem period (on or before time of death) poses a number of unique challenges for laboratorians and clinicians. An expert in this area outlines a plan for dealing with concerns, emphasizing appropriate laboratory stewardship and excellent care for both patients and patients’ families.

Ask the Expert


Gurmukh Singh, MD, PhD, MBA, discusses why labs should report incidental findings from serum protein electrophoresis and serum immunofixation electrophoresis, instead of solely focusing on whether or not monoclonal immunoglobulins are present.

Bench Matters


Federal Insider


Twenty associations, clinical laboratories, and in vitro diagnostics companies joined an AACC-led coalition calling on Congress to increase funding for the Centers for Disease Control and Prevention (CDC) to continue its efforts to harmonize the reporting of clinical laboratory test results.

Industry Playbook


Regulatory Roundup


The Sample